Home LiteratureArticle Details
PMID: 6974777 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Inferences on the nature of the apical sodium entry site in frog skin epithelium.

The Journal of pharmacology and experimental therapeutics ·Vol. 219 ·No. 2 ·1981-11-00 ·Pages 481-8

Benos DJ, Watthey JW

Abstract

The inhibition and stimulation of short-circuit current in in vitro frog skin by a series of structural analogs of the diuretic drug amiloride were studied. Also, the inhibitory profile of a new experimental diuretic, 3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine, or CGS 4270, was determined. The major conclusions of our studies are: 1) amiloride remains the most effective inhibitor of Na+ entry, with both the pyrazine ring and the acylguanidine moiety being required for maximum activity; 2) CGS 4270 also inhibits Na+ transport in frog skin; it acts only from the external solution, is uncharged, is noncompetitive with Na+ and interacts noncompetitively with amiloride; the inhibition is independent of external calcium; and 3) benzimidazole increases amiloride-sensitive short-circuit current and this compound is competitive with amiloride. These results indicate that the putative Na+ entry protein contains multiple inhibitory sites and that compounds which stimulate Na+ entry may also bind at the same molecular locus as an inhibitor.

MeSH Terms
Amiloride/analogs & derivatives,pharmacology Animals Benzimidazoles/pharmacology Biological Transport/drug effects Epithelium/drug effects,metabolism In Vitro Techniques Oxadiazoles/pharmacology Pyrazines/pharmacology Rana catesbeiana Skin/drug effects,metabolism Sodium/metabolism Structure-Activity Relationship
Chemicals
Benzimidazoles Oxadiazoles Pyrazines 3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine Amiloride Sodium benzimidazole
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Benos D J
Watthey J W
Article Info
Journal
The Journal of pharmacology and experimental therapeutics
Abbr.
J Pharmacol Exp Ther
ISSN
0022-3565
Published
1981-11-00
Pages
481-8
Language
English
Region
United States
NLM ID
0376362
Subset
IM
Grants
NIADDK NIH HHS · AM-25886 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]